Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove, Gene Express to Co-Market Lung Cancer Risk Test

NEW YORK (GenomeWeb News) – BioTrove and Gene Express have struck an agreement to co-market a test for profiling certain indicators for the risk of lung cancer, BioTrove said today.
The test, called the Standardized NanoArray PCR, or SNAP, gene expression profiling system, uses BioTrove’s OpenArray nanofluidic PCR platform, Gene Express’ PCR measurement standards, and clinical knowledge from the University of Rochester School of Medicine and Dentistry.
The PCR analysis profiling system is a novel method for “consistent and accurate lung cancer risk analysis” that may be used in diagnostic laboratories or community hospitals, BioTrove said.
David Lester, Gene Express’ chief technology officer, said in a statement that the SNAP system “simplifies and standardizes” lab workflows and makes “genetic profiling viable and translatable” in diagnostic labs.
BioTrove’s OpenArray system allows scientists to conduct up to 3,072 independent PCR analyses simultaneously on up to 144 samples in a single plate, while Gene Express’ Standardized RT PCR, or StaRT-PCR, control for false negatives and false positives, BioTrove said.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.